Shuttle Pharmaceuticals
SHPH
3 hedge funds and large institutions have $34.6K invested in Shuttle Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
29% more capital invested
Capital invested by funds: $26.8K → $34.6K (+$7.81K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$17.8K |
| 2 |
VF
Virtu Financial
New York
|
+$849 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.55K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$455 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$22 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $16.9K | +$17.8K | +21 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $12.3K | -$2.55K | -3 | -17% |
|
|
VF
3
Virtu Financial
New York
| $5K | +$849 | +1 | +20% |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $200 | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $172 | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $22 | – | – | – |
|
|
7
Renaissance Technologies
New York
| – | -$7K | -8 | Closed |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$455 | -1 | Closed |
|
|
9
Wells Fargo
San Francisco,
California
| – | -$22 | – | – |
|
SHPH Hedge Fund Activity: Q2 2024 in Review
3 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q2 2024, worth a combined $34.6K — up 29% from $26.8K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of SHPH and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $17.8K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $7K sold.
- 3 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q2 2024, down from 4 in Q1 2024.
- Funds reported $34.6K of Shuttle Pharmaceuticals stock for Q2 2024, up 29% quarter-over-quarter.
- 1 fund opened new Shuttle Pharmaceuticals positions in Q2 2024 and 2 closed out, a net change of -1 holder.
- The largest Shuttle Pharmaceuticals buyer in Q2 2024 was Two Sigma Securities, an estimated $17.8K added.
- The largest Shuttle Pharmaceuticals seller in Q2 2024 was Renaissance Technologies, an estimated $7K sold.
Based on aggregated 13F filings for Q2 2024.